The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
Status:
Recruiting
Trial end date:
2021-07-31
Target enrollment:
Participant gender:
Summary
Single-arm, open-label, single center study to assess the efficacy and safety of terbutaline
plus danazol in patients with corticosteroid resistant/relapsed ITP.